{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T23:59:27Z","timestamp":1785110367245,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Pfizer Japan, Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Migraine is globally more prevalent in females; however, the clinical and social burden among males remains insufficiently characterized. This study aimed to describe the clinical features and social burden of migraine in Japanese males to identify sex-specific migraine profiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional, population-based web survey was conducted among Japanese adults aged\u2009\u2265\u200918 years diagnosed with migraine according to modified criteria from the International Classification of Headache Disorders, Third Edition (ICHD-3). Participants were grouped by sex; females diagnosed with menstrual migraine (MM) were excluded to minimize hormonal confounding. Key outcomes included pain intensity (Visual Analog Scale [VAS]), pain duration, and social burden assessed using validated instruments: Migraine Interictal Burden Scale (MIBS-4), Migraine Disability Assessment (MIDAS), Migraine-Specific Quality of Life Questionnaire (MSQ), and Work Productivity and Activity Impairment for Migraine (WPAI-M) scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 266,392 individuals screened, 18,750 completed the survey; 4,161 males and 9,997 females (excluding those with MM) were included in the analysis. Males were older (mean\u00b1 standard deviation age: 43.9\u2009\u00b1\u200912.4 vs. 40.9\u2009\u00b1\u200912.2 years) and reported more lifestyle-related triggers (e.g., alcohol, irregular eating, and overexercise). Males, compared to females, experienced greater pain intensity (VAS: 57.1\u2009\u00b1\u200916.7 vs. 54.9\u2009\u00b1\u200919.6;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) but shorter pain duration (6.3\u2009\u00b1\u20099.4 vs. 7.9\u2009\u00b1\u200912.4\u00a0h;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). MIDAS scores were comparable (6.3\u2009\u00b1\u200910.8 vs. 6.0\u2009\u00b1\u20099.6;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.283), while MIBS-4 scores were higher in males (4.0\u2009\u00b1\u20093.5 vs. 3.3\u2009\u00b1\u20093.3;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). MSQ scores were lower in males for domains of interference (83.5\u2009\u00b1\u200920.0 vs. 85.4\u2009\u00b1\u200918.3;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001) and emotional function (80.2\u2009\u00b1\u200920.9 vs. 81.8\u2009\u00b1\u200920.3;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007). Work-related impairment was more pronounced in males than in females, with higher absenteeism (4.7\u2009\u00b1\u200914.1 vs. 3.4\u2009\u00b1\u200912.7;\n                      <jats:italic>p\u2009=<\/jats:italic>\n                      \u20090.001), presenteeism (31.5\u2009\u00b1\u200922.9 vs. 29.5\u2009\u00b1\u200923.1;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007), and overall work impairment (33.6\u2009\u00b1\u200924.6 vs. 30.9\u2009\u00b1\u200924.3;\n                      <jats:italic>p\u2009=<\/jats:italic>\n                      \u20090.001). Preventive medication use was higher in males (oral: 40.8% vs. 34.3%; injectables: 3.3% vs. 1.7%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Males with migraine exhibited a greater burden in terms of pain intensity and functional impairment relative to females without MM. These findings support the development of sex-specific and individualized management strategies that incorporate both pharmacological and lifestyle interventions to reduce disease burden and enhance patient-centered care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-026-02405-z","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:07:22Z","timestamp":1779937642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and social burden of migraine in Japanese males: a cross-sectional comparison with females without menstrual migraine"],"prefix":"10.1186","volume":"27","author":[{"given":"Tsubasa","family":"Takizawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-3601","authenticated-orcid":false,"given":"Reiko","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanae","family":"Togo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"2405_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40122-024-00690-7","volume":"14","author":"L Dong","year":"2025","unstructured":"Dong L, Dong W, Jin Y et al (2025) The Global Burden of Migraine: A 30-year trend review and future projections by age, sex, country, and region. Pain Ther 14:297\u2013315. https:\/\/doi.org\/10.1007\/s40122-024-00690-7","journal-title":"Pain Ther"},{"key":"2405_CR2","unstructured":"Al Khalili Y, Asuncion RMD, Chopra P (2025) Migraine headache in childhood. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK557813\/"},{"key":"2405_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1468-2982.1997.1701015.x","volume":"17","author":"F Sakai","year":"1997","unstructured":"Sakai F, Igarashi H (1997) Prevalence of migraine in Japan. Cephalalgia 17:15\u201322. https:\/\/doi.org\/10.1046\/j.1468-2982.1997.1701015.x","journal-title":"Cephalalgia"},{"key":"2405_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-019-0995-y","volume":"20","author":"Y Guo","year":"2019","unstructured":"Guo Y, Xu S, Nie S et al (2019) Female versus male migraine: an event-related potential study of visual neurocognitive processing. J Headache Pain 20:38. https:\/\/doi.org\/10.1186\/s10194-019-0995-y","journal-title":"J Headache Pain"},{"key":"2405_CR5","doi-asserted-by":"publisher","first-page":"e065787","DOI":"10.1136\/bmjopen-2022-065787","volume":"12","author":"S Kikui","year":"2022","unstructured":"Kikui S, Chen Y, Ikeda K et al (2022) Comorbidities in patients with migraine in Japan: a cross-sectional study using data from National Health and Wellness Survey. BMJ Open 12:e065787. https:\/\/doi.org\/10.1136\/bmjopen-2022-065787","journal-title":"BMJ Open"},{"key":"2405_CR6","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/head.12150","volume":"53","author":"DC Buse","year":"2013","unstructured":"Buse DC, Loder EW, Gorman JA et al (2013) Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache: J Head Face Pain 53:1278\u20131299. https:\/\/doi.org\/10.1111\/head.12150","journal-title":"Headache: J Head Face Pain"},{"key":"2405_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s10194-024-01936-7","volume":"26","author":"MP Fitzek","year":"2025","unstructured":"Fitzek MP, Boucherie DM, de Vries T et al (2025) Migraine in men. J Headache Pain 26:3. https:\/\/doi.org\/10.1186\/s10194-024-01936-7","journal-title":"J Headache Pain"},{"key":"2405_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/head.14488","volume":"63","author":"IE Verhagen","year":"2023","unstructured":"Verhagen IE, van der Arend BWH, van Casteren DS et al (2023) Sex differences in migraine attack characteristics: A longitudinal E-diary study. Headache: J Head Face Pain 63:333\u2013341. https:\/\/doi.org\/10.1111\/head.14488","journal-title":"Headache: J Head Face Pain"},{"key":"2405_CR9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1177\/0333102416677999","volume":"37","author":"N Maleki","year":"2017","unstructured":"Maleki N, Kurth T, Field AE (2017) Age at menarche and risk of developing migraine or non-migraine headaches by young adulthood: A prospective cohort study. Cephalalgia 37:1257\u20131263. https:\/\/doi.org\/10.1177\/0333102416677999","journal-title":"Cephalalgia"},{"key":"2405_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/jwh.2018.7274","volume":"27","author":"RA Schroeder","year":"2018","unstructured":"Schroeder RA, Brandes J, Buse DC et al (2018) Sex and gender differences in migraine\u2014evaluating knowledge gaps. J Womens Health 27:965\u2013973. https:\/\/doi.org\/10.1089\/jwh.2018.7274","journal-title":"J Womens Health"},{"key":"2405_CR11","doi-asserted-by":"publisher","unstructured":"Karceski S (2023) Migraine and hormones. Neurology 100. https:\/\/doi.org\/10.1212\/WNL.0000000000207273","DOI":"10.1212\/WNL.0000000000207273"},{"key":"2405_CR12","unstructured":"IHS classification ICHD-3 (2024) Migraine. https:\/\/ichd-3.org\/1-migraine\/\u00a0Accessed 19 Nov 2024."},{"key":"2405_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s10194-025-02117-w","volume":"26","author":"M Waliszewska-Pros\u00f3\u0142","year":"2025","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Marschollek K, Budrewicz S et al (2025) Migraine in men \u2013 differences in phenotype and treatment patterns: results from the Migraine in Poland cross-sectional national survey. J Headache Pain 26:173. https:\/\/doi.org\/10.1186\/s10194-025-02117-w","journal-title":"J Headache Pain"},{"key":"2405_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s10194-024-01722-5","volume":"25","author":"T Takizawa","year":"2024","unstructured":"Takizawa T, Kitano T, Iijima M et al (2024) Treatment patterns and characteristics of patients with migraine: results from a retrospective database study in Japan. J Headache Pain 25:19. https:\/\/doi.org\/10.1186\/s10194-024-01722-5","journal-title":"J Headache Pain"},{"key":"2405_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1526-4610.2007.00814.x","volume":"47","author":"GE Tietjen","year":"2007","unstructured":"Tietjen GE, Herial NA, Hardgrove J et al (2007) Migraine comorbidity constellations. Headache: J Head Face Pain 47:857\u2013865. https:\/\/doi.org\/10.1111\/j.1526-4610.2007.00814.x","journal-title":"Headache: J Head Face Pain"},{"key":"2405_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10072-020-04643-8","volume":"41","author":"G Allais","year":"2020","unstructured":"Allais G, Chiarle G, Sinigaglia S et al (2020) Gender-related differences in migraine. Neurol Sci 41:429\u2013436. https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s10072-020-04643-8","journal-title":"Neurol Sci"},{"key":"2405_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s10194-025-02219-5","volume":"26","author":"T Takizawa","year":"2025","unstructured":"Takizawa T, Ihara K, Yoshikawa R et al (2025) Clinical characteristics and social burden of menstrual migraine in Japan: an online-based cross-sectional questionnaire study. J Headache Pain 26:276. https:\/\/doi.org\/10.1186\/s10194-025-02219-5","journal-title":"J Headache Pain"},{"key":"2405_CR18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4065\/84.5.422","volume":"84","author":"DC Buse","year":"2009","unstructured":"Buse DC, Rupnow MFT, Lipton RB (2009) Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc 84:422\u2013435. https:\/\/doi.org\/10.4065\/84.5.422","journal-title":"Mayo Clin Proc"},{"key":"2405_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1526-4610.2003.03069.x","volume":"43","author":"M Iigaya","year":"2003","unstructured":"Iigaya M, Sakai F, Kolodner KB et al (2003) Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire. Headache: J Head Face Pain 43:343\u2013352. https:\/\/doi.org\/10.1046\/j.1526-4610.2003.03069.x","journal-title":"Headache: J Head Face Pain"},{"key":"2405_CR20","first-page":"449","volume":"21","author":"F Sakai","year":"2004","unstructured":"Sakai F, Fukuuchi Y, Iwata M (2004) Reliability and validity of the Japanese version of the migraine quality of life survey [in Japanese]. Neurol Ther 21:449\u2013458","journal-title":"Neurol Ther"},{"key":"2405_CR21","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1023\/B:QURE.0000040787.20364.89","volume":"13","author":"S Ohbu","year":"2004","unstructured":"Ohbu S, Igarashi H, Okayasu H et al (2004) Development and testing of the Japanese version of the migraine-specific quality of life instrument. Qual Life Res 13:1489\u20131493. https:\/\/doi.org\/10.1023\/B:QURE.0000040787.20364.89","journal-title":"Qual Life Res"},{"key":"2405_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s41687-023-00552-4","volume":"7","author":"JH Ford","year":"2023","unstructured":"Ford JH, Ye W, Ayer DW et al (2023) Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine. J Patient Rep Outcomes 7:34. https:\/\/doi.org\/10.1186\/s41687-023-00552-4","journal-title":"J Patient Rep Outcomes"},{"key":"2405_CR23","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA (2015) Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34:3661\u20133679. https:\/\/doi.org\/10.1002\/sim.6607","journal-title":"Stat Med"},{"key":"2405_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10194-020-1084-y","volume":"21","author":"DC Buse","year":"2020","unstructured":"Buse DC, Reed ML, Fanning KM et al (2020) Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the Migraine in America Symptoms and Treatment (MAST) study. J Headache Pain 21:23. https:\/\/doi.org\/10.1186\/s10194-020-1084-y","journal-title":"J Headache Pain"},{"key":"2405_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/0333102420974362","volume":"41","author":"DS van Casteren","year":"2021","unstructured":"van Casteren DS, Verhagen IE, Onderwater GL et al (2021) Sex differences in prevalence of migraine trigger factors: A cross-sectional study. Cephalalgia 41:643\u2013648. https:\/\/doi.org\/10.1177\/0333102420974362","journal-title":"Cephalalgia"},{"key":"2405_CR26","doi-asserted-by":"publisher","unstructured":"Sakai F, Hirata K, Igarashi H et al (2022) A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan. J Headache Pain 23. https:\/\/doi.org\/10.1186\/s10194-022-01439-3","DOI":"10.1186\/s10194-022-01439-3"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02405-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02405-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02405-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T23:27:18Z","timestamp":1785108438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02405-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2405"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02405-z","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted following approval from the Non-Profit Organization MINS Research Ethics Committee (MINS-REC-240229). Informed consent was obtained electronically from all participants before study initiation. Participants were allowed to withdraw their consent at any time without disclosing the reason, by contacting the Macromill Monitor Support System.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TT is a consultant\/advisor and\/or serves on advisory boards for Pfizer, Eli Lilly, Otsuka, Amgen, Daiichi Sankyo, AbbVie, and Teijin, and has received speaker honoraria from Pfizer, Daiichi Sankyo, Eli Lilly, Otsuka, Amgen, Sawai, Eisai, and Takeda, as well as grant\/funding from Eli Lilly, Pfizer, and Tsumura, outside the submitted work. TT serves as a Junior Editor of The Journal of Headache and Pain and was not involved in the review process or editorial decision for this manuscript. RY, KT, TK, and MI are employees of Pfizer Japan Inc. KT and MI are shareholders of Pfizer Inc. KI has no competing interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"191"}}